the only concern which is quite obvious is the weak sell side volume. Volume has to be created when nobody wants to sell...
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025